Intensity learning for Parkinson's (NCT07403539)
Improve speech clarity through listening
- Trial ID
- NCT07403539
- Official Title
- Relationship Between Speech Perceptual Learning and Speech Production in Parkinson's Disease
- Goal
- Improve speech clarity through listening
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- State University of New York at Buffalo
- Study Type
- INTERVENTIONAL
- Enrollment
- 50 participants
- Conditions
- Parkinson's Disease
- Interventions
- Intensity learning, Intensity discrimination, Rate learning, Rate discrimination
Summary For Families
The goal is to see whether trouble hearing and learning speech patterns in people with Parkinson's is linked to the way they speak, so therapies can be tailored to help both understanding and speaking more clearly. Participants will record speech and do listening and learning tasks that test or train how well they pick up on speaking speed and loudness in other people, while researchers measure the sounds and have everyday listeners rate how understandable and effortful the speech is. The trial is looking for U.S. Residents aged 45 or older with Parkinson's who are native North American English speakers and who take a medication that includes levodopa; people with other language, hearing, or major brain problems, or who use a hearing aid or cochlear implant, are not eligible.
Locations
- State University of New York at Buffalo, Buffalo, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Intensity learning. The goal is to see whether trouble hearing and learning speech patterns in people with Parkinson's is linked to the way they speak, so therapies can be tailored to help both understanding and speaking more clearly. Participants will record speech and do listening and learning tasks that test or train how well they pick up on speaking speed and loudness in other people, while researchers measure the sounds and have everyday listeners rate how understandable and effortful the speech is. The trial is looking for U.S. Residents aged 45 or older with Parkinson's who are native North American English speakers and who take a medication that includes levodopa; people with other language, hearing, or major brain problems, or who use a hearing aid or cochlear implant, are not eligible.
- Who can participate?
- Participants must be at least 45 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.